In drug sensitivity analysis, the expression of CDKN2A, DLAT, PDHA1, and GLS was negatively associated with some or most drugs in the Cancer Therapy Response Portal database, and the expression of DLST positively correlated (Figure 10A). This evidence concerns the gene CDKN2A and cancer.